Clinical Trial Update: Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression [Phase 4]

View source ↗

Summary

A Phase 4 open trial evaluating duloxetine in outpatients with irritable bowel syndrome symptoms and comorbid major depression has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome
• Major Depressive Disorder

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Major Depression, Irritable Bowel Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2016-11-25